Advertisement

bones

Odanacatib for Postmenopausal Osteoporosis

Postmenopausal osteoporosis is a bone disease characterized by the loss of too much bone from the body after menopause. Odanacatib is a cathepsin K inhibitor that reduces bone resorption and maintains bone formation. The...

Loading

Advertisement

For latest news and updates
Email-id is invalid

Meeting Coverage